AIS
GNMK

AlphaOne Investment Services’s GenMark Diagnostics, Inc GNMK Stock Holding History

AlphaOne Investment Services’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,900
Closed -$37K – 478
2017
Q4 		$37K Buy
8,900
+6,800
+324% +$40.9K 0.01% 223
2017
Q3 		$20K Buy
+2,100
New +$21.8K 0.01% 267
2015
Q1 		– Sell
-16,102
Closed -$219K – 108
2014
Q4 		$219K Buy
16,102
+2,400
+18% +$26.8K 0.08% 97
2014
Q3 		$123K Buy
+13,702
New +$147K 0.04% 101

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AlphaOne Investment Services's GNMK Position: Q1 2018 in Review

AlphaOne Investment Services sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2018, closing a stake of 8,900 shares — an estimated $37K sold.

AlphaOne Investment Services first reported a position in GNMK in Q3 2014 and held it in 4 quarters. The position peaked at $219K in Q4 2014. 98 funds tracked by Wall St. Rank hold GNMK as of Q1 2018.

  • AlphaOne Investment Services reported no remaining GenMark Diagnostics, Inc position as of Q1 2018 after selling out during the quarter.
  • AlphaOne Investment Services sold 8,900 GenMark Diagnostics, Inc shares in Q1 2018, an estimated $37K.
  • AlphaOne Investment Services first reported a position in GenMark Diagnostics, Inc in Q3 2014 and held it in 4 quarters.
  • AlphaOne Investment Services's GenMark Diagnostics, Inc position peaked at $219K in Q4 2014.
  • 98 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2018.

Based on AlphaOne Investment Services's 13F filing for Q1 2018, filed 14 May 2018.